Alto Neuroscience, Inc. ANRO
28.47 USD +3.30 (+13.14%)
Nov 9, 2026, 11:49 AM EST
25.02 Day range 29.49
10.80 52-week range 37.48
- YTD
- +59.92%
- 1 year
- +146.45%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -66.36M | -68.61M | -37.81M | -29.19M | -12.06M | |
| -63.24M | -61.43M | -36.30M | -27.71M | -9.19M | |
| -2.19 | -2.50 | -9.73 | -8.04 | -1.71 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 176.98M | 168.73M | 82.55M | 48.34M | 25.70M | |
| 184.69M | 177.54M | 86.63M | 50.85M | 28.79M | |
| 33.55M | 26.08M | 16.82M | 17.02M | 3.11M | |
| 22.81M | 16.07M | 9.86M | 9.46M | 0 | |
| 151.14M | 151.46M | -71.67M | -38.41M | -12.48M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -51.77M | -47.42M | -33.45M | -20.39M | -9.26M | |
| -24.00K | -2.08M | -470.00K | -732.00K | -680.00K | |
| 60.08M | 135.69M | 68.13M | 43.79M | 31.69M | |
| -24.00K | -2.08M | -470.00K | -732.00K | -680.00K | |
| 8.26M | 86.18M | 34.20M | 22.64M | 21.70M |